# Use of Sugammadex for Reversal of Paralysis in Microlaryngoscopy

> **NCT03111121** · PHASE4 · COMPLETED · sponsor: **West Virginia University** · enrollment: 79 (actual)

## Conditions studied

- Microlaryngoscopy
- Rigid Bronchoscopy

## Interventions

- **DRUG:** Sugammadex
- **DRUG:** neostigmine
- **DRUG:** glycopyrrolate

## Key facts

- **NCT ID:** NCT03111121
- **Lead sponsor:** West Virginia University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-04
- **Primary completion:** 2018-06-22
- **Final completion:** 2019-05-30
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2025-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03111121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03111121, "Use of Sugammadex for Reversal of Paralysis in Microlaryngoscopy". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03111121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*